Evidence map›Paper›PMID 42497423›Full record

ArticleGenes, chromosomes & cancer2026

Intramuscular Myoepithelioma-Like Hyalinizing Epithelioid Tumor With OGT::FOXO3 Intraexonic DNA Fusion Confirmed by Nanopore Sequencing.

Naoki Takeda, Naohiro Makise, Hajime Kageyama, Mariko Oikawa, Yusuke Amano, Takahiro Sugiyama, Hideyuki Kinoshita, Yoko Hagiwara, Hiroto Kamoda, Tsukasa Yonemoto and 2 more

Abstract readCase Reports
In one paragraph

Article in Genes, chromosomes & cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naoki TakedaDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.ORCID https://orcid.org/0009-0008-2362-7179
Naohiro MakiseDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.ORCID https://orcid.org/0000-0002-6991-747X
Hajime KageyamaDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.
Mariko OikawaDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.
Yusuke AmanoDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.ORCID https://orcid.org/0000-0002-4056-3487
Takahiro SugiyamaDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.
Hideyuki KinoshitaDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.ORCID https://orcid.org/0000-0002-0515-088X
Yoko HagiwaraDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
Hiroto KamodaDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.ORCID https://orcid.org/0000-0001-8982-2278
Tsukasa YonemotoDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
Masahito KawazuDivision of Cell Therapy, Chiba Cancer Center, Chiba, Japan.ORCID https://orcid.org/0000-0003-4146-3629
Akinobu ArakiDivision of Surgical Pathology, Chiba Cancer Center, Chiba, Japan.

Funding

Foundation for Promotion of Cancer Research in JapanIchiro Kanehara Foundation for the Promotion of Medical Sciences and Medical CareJapan Society for the Promotion of Science JP23K06438Takeda Science Foundation
6 · The paper itself

Abstract

Myoepithelioma-like hyalinizing epithelioid tumor (MHET) is a rare mesenchymal neoplasm characterized by rearrangements of the OGT gene. MHET typically presents as a small tumor in the subcutis and generally follows a benign clinical course. Histologically, MHET is characterized by a hyalinized stroma exhibiting a distinctive "two-tone" appearance, epithelioid tumor cells with cellular processes encircling matrix globules, and a minor spindle cell component. The tumor also demonstrates rich vasculature with occasional fringe-like vessels, accompanied by perivascular concentric spindle cell proliferation and hyalinization. Nearly all documented OGT fusions in MHET are intraexonic; however, their precise genomic DNA breakpoints and the mechanisms underlying fusion transcript generation remain unclear. We report a case of MHET in a 17-year-old boy and investigate the genomic breakpoint of the fusion gene. Although the tumor showed atypical features, including large size, intramuscular location, and focal cytokeratin (CAM5.2) expression, the histologic findings were characteristic of MHET. Reverse transcription-polymerase chain reaction (RT-PCR) identified an intraexonic, in-frame OGT::FOXO3 fusion transcript. To clarify the genomic breakpoint, nanopore DNA sequencing demonstrated that the DNA breakpoint was identical to the fusion junction in the mRNA transcript. These findings demonstrate that the fusion transcript was generated directly from rearranged genomic DNA without splice site involvement. This mechanism may contribute to the rarity of MHET and warrants further investigation.

Indexed as

Forkhead Box Protein O3MyoepitheliomaOncogene Proteins, FusionOrnithine-Oxo-Acid TransaminaseHumansMaleN-AcetylglucosaminyltransferasesNanopore SequencingForkhead Box Protein O3FOXO3 protein, humanN-AcetylglucosaminyltransferasesOGT protein, humanOncogene Proteins, FusionOrnithine-Oxo-Acid TransaminaseFOXO3intraexonic fusionmesenchymal tumormyoepithelioma‐like hyalinizing epithelioid tumornanopore sequencingOGT

Identifiers

PMID42497423
PMCPMC13399998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.